Eli Lilly's weight loss drug tirzepatide has received approval from Chinese regulators, intensifying competition with Novo Nordisk.
↧
Channel:
Directional Combination Forecast Trade: Consumer Sentiment Final in 14 Days: April 11, 2025
X
Are you the publisher?
Claim or
contact us
about this channel.
X
0
Channel Details:
- Title: Directional Combination Forecast Trade: Consumer Sentiment Final in 14 Days: April 11, 2025
- Channel Number: 79263048
- Language: English
- Registered On: April 19, 2024, 1:58 am
- Number of Articles: 2158
- Latest Snapshot: April 11, 2025, 10:41 pm
- RSS URL: https://ibkrcampus.com/feed/feed
- Publisher: https://www.interactivebrokers.com/campus/feed/
- Description: Financial Education from Interactive Brokers
- Catalog: //uptrend56.rssing.com/catalog.php?indx=79263048
© 2025 //www.rssing.com